dangers of glp 1 GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution – The Chicago Council on Science and Technology As the popularity of GLP-1
Description
Encouraging tolerability through 100 mg daily dosing with oral VK2735
These products are not intended to diagnose, treat, cure, or prevent any disease
The proposed mechanism centers on the gut microbiome's role in metabolic regulation
This is semaglutide, a GLP-1 receptor agonist
The study has the following limitations: (1) underreporting and selection bias in FAERS data,as it lacks a comprehensive list of concomitant medications, which may lead to biased analysis results
But when gastric emptying slows down on a GLP-1 medication like semaglutide or tirzepatide , the equation changes dramatically
